Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton.
Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Curr Opin Infect Dis. 2019 Oct;32(5):490-496. doi: 10.1097/QCO.0000000000000585.
Nonpathogenic commensal Neisseria are rarely considered in the clinical setting despite evidence that they can cause invasive opportunistic infections. In contrast, they may offer protection against pathogenic Neisseria, and such relationships are being actively explored in experimental studies.
Recent case reports are presented of invasive infection caused by nonpathogenic Neisseria in patients on novel biologic therapies. On the other hand, Neisseria lactamica, a nonpathogenic commensal, has been shown in human challenge studies to inhibit colonization by Neisseria meningitidis. Experimental mouse models have also explored the inhibitory effects of nonpathogenic Neisseria on Neisseria gonnhoreae infection. Cutting-edge advances in metagenomics and microbiomics are being used to understand the mechanisms underpinning these effects.
Clinicians should have increased awareness of nonpathogenic Neisseria. First, as new immunomodulating therapies become licenced, the interactions that maintain balance between commensals and their human hosts may be altered. Second, these bacteria are showing promise in their capacity to exclude pathogenic Neisseria species from their anatomical niches.
尽管有证据表明,非致病性共生奈瑟菌可引起侵袭性机会性感染,但在临床环境中很少考虑它们。相比之下,它们可能对致病性奈瑟菌提供保护,并且这些关系正在实验研究中得到积极探索。
最近提出了一些病例报告,在接受新型生物治疗的患者中,由非致病性奈瑟菌引起的侵袭性感染。另一方面,非致病性共生奈瑟菌已在人体挑战研究中显示,它可抑制脑膜炎奈瑟菌的定植。实验性小鼠模型也探讨了非致病性奈瑟菌对淋病奈瑟菌感染的抑制作用。宏基因组学和微生物组学的前沿进展正在被用于理解这些作用的潜在机制。
临床医生应该提高对非致病性奈瑟菌的认识。首先,随着新的免疫调节治疗方法获得许可,维持共生菌与其人类宿主之间平衡的相互作用可能会发生改变。其次,这些细菌在排除其解剖部位的致病性奈瑟菌方面显示出了良好的效果。